Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Features ESC Heart Failure 2019

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Shelley Wood

May 30, 2019

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Conference News TCT 2018

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Shelley Wood

September 23, 2018

News Conference News PCR London Valves 2018

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Shelley Wood

September 10, 2018

News Conference News The Structural Heart Disease Summit 2018

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Shelley Wood

June 22, 2018

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

Presentation

Cardiac Resynchronization Therapy for Mitral Regurgitation

Presenter: Raul D. Mitrani

October 31, 2015

Presentation TCT 2014

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Saibal Kar

September 16, 2014

Presentation TCT 2014

TCT 788: Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High-Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Blase A. Carabello, Allan Schwartz, Charles J. Davidson, Saibal Kar

September 13, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Conference News AHA 2013

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Yael L. Maxwell

November 19, 2013

Advertisement

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Roughly 80% of ESC Guideline Writers Have Financial COIs

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Cardiac Resynchronization Therapy for Mitral Regurgitation

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

TCT 788: Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High-Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Similar Long-term Benefits With Mitral Valve Repair, Replacement for Ischemic MR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content